Search

Mikael Rinne Phones & Addresses

  • 21 Kent St APT 2, Brookline, MA 02445 (317) 498-1729
  • Indianapolis, IN
  • Bowling Green, KY
  • Windermere, FL
  • Highland, UT
  • W Lafayette, IN
  • West Lafayette, IN
  • Falmouth, ME
  • 21 Kent St #2, Brookline, MA 02445

Work

Company: Dana-Farber Cancer Institute Address: 450 Brookline Ave, Boston, MA 02215 Phones: (617) 632-3000

Education

School / High School: In Univ Sch Of Med 2002

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Neurology, 2010

Specialities

Neurology

Professional Records

Medicine Doctors

Mikael Rinne Photo 1

Dr. Mikael L Rinne, Boston MA - MD (Doctor of Medicine)

View page
Specialties:
Neurology
Age:
48
Address:
55 Fruit St, Boston, MA 02114

Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215
(617) 632-3000 (Phone)
Certifications:
Neurology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
In Univ Sch Of Med
Graduated: 2002
Medical School
Massachusetts General Hospital
Graduated: 2002
Medical School
St Vincent'S
Graduated: 2002
Mikael Rinne Photo 2

Mikael L. Rinne

View page
Specialties:
Neurology, Medical Oncology
Work:
Dana-Farber Cancer Institute Center For Neurology-Oncology
450 Brookline Ave FL 10, Boston, MA 02215
(617) 632-6633 (phone), (617) 632-4773 (fax)
Education:
Medical School
Indiana University School of Medicine
Graduated: 2006
Conditions:
Epilepsy
Migraine Headache
Peripheral Nerve Disorders
Languages:
Chinese
English
French
Spanish
Description:
Dr. Rinne graduated from the Indiana University School of Medicine in 2006. He works in Boston, MA and specializes in Neurology and Medical Oncology. Dr. Rinne is affiliated with Boston Childrens Hospital, Brigham & Womens Hospital and MassGeneral For Children At North Shore Medical Center.
Mikael Rinne Photo 3

Mikael Rinne, Boston MA

Work:
Dana-Farber Cancer Institute
450 Brookline Ave, Boston, MA 02215
Binney Medical Associates
20 Prospect St, Milford, MA 01757
Binney Medical Associates
1153 Centre St, Jamaica Plain, MA 02130
Dana Farber Cancer
40 Buttrick Rd, Londonderry, NH 03053
Binney Medical Associates
101 Columbian St, South Weymouth, MA 02190
Mikael Rinne Photo 4

Mikael Lee Rinne, Boston MA

View page
Specialties:
Neurologist
Address:
450 Brookline Ave, Boston, MA 02215
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Mikael Lee Rinne
Mikael Rinne MD,PHD
Neurologist
450 Brookline Ave, Boston, MA 02215
(617) 632-3000

Publications

Us Patents

Combination Comprising A Tim-3 Inhibitor And A Hypomethylating Agent For Use In Treating Myelodysplastic Syndrome Or Chronic Myelomonocytic Leukemia

View page
US Patent:
20230058489, Feb 23, 2023
Filed:
Jan 15, 2021
Appl. No.:
17/758671
Inventors:
- Basel, CH
Mikael RINNE - Cambridge MA, US
Kamel MALEK - Basel, CH
International Classification:
C07K 16/28
A61P 35/02
Abstract:
Combination therapies comprising TIM-3 inhibitors are disclosed. The combinations can be used to treat cancerous conditions and disorders, including hematologic cancers.

Rapid Quantitative Detection Of Single Nucleotide Polymorphisms Or Somatic Variants And Methods To Identify Malignant Neoplasms

View page
US Patent:
20170369939, Dec 28, 2017
Filed:
Dec 22, 2015
Appl. No.:
15/538382
Inventors:
MATTHEW MEYERSON - BOSTON MA, US
GANESH M. SHANKAR - BOSTON MA, US
JOSHUA M. FRANCIS - CAMBRIDGE MA, US
DANIEL P. CAHILL - BOSTON MA, US
MIKAEL L. RINNE - BOSTON MA, US
- CAMBRIDGE MA, US
- BOSTON MA, US
Assignee:
THE BROAD INSTITUTE, INC. - CAMBRIDGE MA
DANA-FARBER CANCER INSTITUTE, INC. - BOSTON MA
THE GENERAL HOSPITAL CORPORATION - BOSTON MA
International Classification:
C12Q 1/68
Abstract:
Provided are systems, kits, and methods for the quantitative detection of single nucleotide polymorphisms or variants to identify malignant neoplasms. The methods include use of modified oligonucleotide blockers with peptide nucleic acid backbones that hybridize to and block logarithmic amplification of the wild-type alleles of a target, and incorporation of locked nucleic acids into probes that are complementary to a mutant allele of the target sequence to increase specificity. The methods include detection of variants in sequences with high GC content and/or low complexity, such as the TERT promoter, IDH1, BRAF, NRAS, GNAQ, GNA11 and H3F3 A gene variants. The methods include sensitive detection and staging of cancers with low cellularity, and can be used intraoperatively such as for glioma, or to detect cell-free circulating tumor DNA, such as for melanoma.
Mikael L Rinne from Brookline, MA, age ~48 Get Report